FDA Approved: COMBIPATCH (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM) — Supplemental Application (Noven Therapeutics, LLC)

View source ↗

Summary

FDA approved a supplemental application for Combipatch (estradiol/norethindrone acetate transdermal system) submitted by Noven Therapeutics, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause-associated Vasomotor Symptoms
• Postmenopausal Osteoporosis

Drugs mentioned

• COMBIPATCH (estradiol/norethindrone acetate transdermal system)

Snippet

SUPPL AP for COMBIPATCH (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM) (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM)